Human immunodeficiency virus‐associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up
This EHA-ESMO Clinical Practice Guideline provides key recommendations for managing HIV-associated lymphomas.The guideline covers clinical, imaging and pathological diagnosis; staging and risk assessment; treatment and follow-up.The author group encompasses a multidisciplinary group of experts from different institutions and countries in Europe.Recommendations are based on available scientific data and the authors' collective expert opinion.
Authors
- Éric Oksenhendler (ORCID: https://orcid.org/0000-0001-8588-7138)
- Simon Collins (ORCID: https://orcid.org/0000-0002-3537-2432)
- Silvia Montoto (ORCID: https://orcid.org/0000-0002-3006-9725)
- Uta Brunnberg
- Philipp Schommers (ORCID: https://orcid.org/0000-0003-3375-6800)
- Kate Cwynarski (ORCID: https://orcid.org/0000-0001-9936-3431)
- Christian Buske (ORCID: https://orcid.org/0000-0002-9782-9012)
- Marcus Hentrich (ORCID: https://orcid.org/0000-0001-5622-348X)
- Christian Hoffmann (ORCID: https://orcid.org/0000-0003-1736-8007)
- Mariana Bastos‐Oreiro (ORCID: https://orcid.org/0000-0002-9431-4646)
- Marie José Kersten (ORCID: https://orcid.org/0000-0002-8904-3802)
- Bastian von Tresckow (ORCID: https://orcid.org/0000-0003-1410-4487)
- Alessandro Re (ORCID: https://orcid.org/0000-0003-1156-6395)
- Chiara M. Cattaneo (ORCID: https://orcid.org/0000-0003-0031-3237)
- Martin Dreyling
- José‐Tomás Navarro (ORCID: https://orcid.org/0000-0001-9101-6013)
- Mark Bower (ORCID: https://orcid.org/0000-0002-4077-6351)
- Caroline Besson (ORCID: https://orcid.org/0000-0003-4364-7173)
- Josep‐María Ribera (ORCID: https://orcid.org/0000-0003-1042-6024)
- Kai Hübel (ORCID: https://orcid.org/0000-0002-7958-4664)
- Igor Aurer (ORCID: https://orcid.org/0000-0001-6175-4277)
- A. J. Davies
- Alessia Dalla Pria (ORCID: https://orcid.org/0000-0002-7421-6002)
Institutions
- Goethe University Frankfurt (DE)
- Universitat Autònoma de Barcelona (ES)
- University College Hospital (GB)
- St Bartholomew's Hospital (GB)
- University Hospital Centre Zagreb (HR)
- Inserm (FR)
- University of Zagreb (HR)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Barts Health NHS Trust (GB)
- Université Paris-Saclay (FR)
- Southampton General Hospital (GB)
- University Hospital Southampton NHS Foundation Trust (GB)
- Hospital General Universitario Gregorio Marañón (ES)
- Josep Carreras Leukaemia Research Institute (ES)
- Northampton General Hospital NHS Trust (GB)
- Krankenhaus vom Roten Kreuz (DE)
- Assistance Publique – Hôpitaux de Paris (FR)
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
- Institut Català d'Oncologia (ES)
- Infektionsmedizinisches Centrum Hamburg (DE)
- École Nationale Supérieure d'Architecture de Versailles (FR)
- Essen University Hospital (DE)
- Institute of Clinical Cancer Research (DE)
- University Hospital Frankfurt (DE)
- Chelsea and Westminster Hospital (GB)
- Hôpital Saint-Louis (FR)
- Amsterdam University Medical Centers (NL)
- University Hospital Cologne (DE)
- University Hospital Ulm (DE)
- Centre Hospitalier de Versailles (FR)
- West German Heart and Vascular Center Essen (DE)
- University College London (GB)
- University of Duisburg-Essen (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- HemaSphere
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/hem3.150
- Citations
- 5
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.12
Funders
- Cancer Research Institute
- Lymphoma Research Foundation
- Amgen
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Gilead Sciences
- Celgene
- CSL Behring
- National Cancer Research Institute
- Regeneron Pharmaceuticals
- ViiV Healthcare
- Jazz Pharmaceuticals
- Les Laboratories Pierre Fabre
- Atara Biotherapeutics
- BeiGene
- Recordati Rare Diseases
- Incyte
- Celltrion
- European Society for Medical Oncology
- Servier
- Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung
- Swedish Orphan Biovitrum
- MorphoSys
- Italfarmaco
- EUSA Pharma
- Lilly Deutschland
- Kite Pharma
- Cilag